Harnessing cell-mediated matrix remodelling by human iPSC-derived intestinal organoids within 3D materials to understand epithelial-mesenchymal intera
Harnessing cell-mediated matrix remodelling by human iPSC-derived intestinal organoids within 3D materials to understand epithelial-mesenchymal intera
批准号:
2241749
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2019
资助国家:
英国
项目状态:
未结题
起止时间:
2019 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PhD project: aims and descriptionThe human intestine can be modelled in vitro using organoids cultured within Matrigel, atumour-derived 3D matrix. However, Matrigel's physical properties, such as its stiffness anddegradability cannot be tuned, which limits our ability to understand how the matrix andmatrix remodeling impacts the intestinal epithelium (and vice versa). The Gentleman Lab hasrecently discovered that stem cells encapsulated within hydrogels with defined physicalproperties remodel their surroundings by secreting matrix proteins locally and by degradingtheir surrounding environment, which impacts their fate (Ferreira, Nat Commun 2018).Here, we will exploit this discovery by melding the Gentleman Lab's (KCL) expertise insynthetic 3D matrices with the Stagg's (QMUL) interests in gut inflammation and the NevesLab's (KCL) organoid-based models of the intestine to develop human organoid-based modelsof IBD within defined, synthetic, modifiable 3D environments, which we will use to askfundamental questions in how the matrix impacts the epithelium (and vice versa) in healthand disease. To accomplish this, we will create human induced pluripotent stem cell (iPSC)-derived intestinal organoids (hIO) and encapsulate them within PEG-based synthetichydrogels in which we can independently modulate stiffness, ligand density anddegradability. Using knockdown/overexpression approaches, microrheology techniques, andhydrogels with controlled softening/stiffening, we will then mechanistically probe how acombination of cell-mediated matrix secretion/degradation and/or altered local mechanicalproperties impact organoid phenotype. This will allow us to identify potential matrix targetswithin the intestinal wall that could be exploited therapeutically.Specific Aims:1. Establish and characterize a human iPSC-derived organoid-based model of IBD bymodulating synthetic hydrogels' physical properties.2. Understand the impact on epithelial and mesenchymal cells of modulating local matrixremodelling around organoids using knockdown and overexpression techniques.3. Understand how modulating local matrix mechanical properties around organoids impactsepithelial and mesenchymal cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
-
批准号:82371145
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:陶永
-
依托单位:
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
-
批准号:82370923
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张文杰
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位: